Cardiac Assist Devices Market 2021 Competitive Analysis

1
Cardiac Assist Devices Market, 2021 - 2027
Copyright Precision Business Insights
2
Market Overview
The Cardiac Assist Devices Market is expected to
rise over the projected period, primarily owing
to greater patient awareness of heart failure and
the provision of improved treatment
alternatives. cardiac assist device is a
mechanical pump that helps people with weaker
hearts as well as it also helps to maintain blood
circulation flow in the heart. Additionally, the
cardiac assist device pulls blood from a lower
chamber of the heart and pump it to the body and
organ systems. In addition, the report
discusses the implications of COVID-19, including
the industry's initial response and strategies
for ensuring business continuity in the coming
years. View Detailed Report Description
3
Market Segments
The global cardiac assist devices market has been
fragmented based on 1. By Type Ventricular
Assist Devices (VDS) (External Ventricular Assist
Devices, Left Ventricular Assist Devices (LVDS),
Biventricular Assist Devices, Right Ventricular
Assist Devices2. By Flow Continuous Flow,
Pulsatile3. By End User Hospitals, Ambulatory
Surgical Centres, Others4. By Geography North
America, Asia Pacific, Europe, Middle East and
Africa, Latin America Request Sample Report
4
Key Players
Some of the major key players in the cardiac
assist devices market areCalon
Cardio-Technology Ltd. (UK) SynCardia Systems,
Inc. (U.S.), Medtronic (U.S.), Berlin Heart
GmbH (Germany), CHF Solutions, Inc. (U.S.),
Teleflex Incorporated (U.S.), MAQUET GmbH Co.
(Germany), Abiomed (U.S.) and Abbot
Laboratories (U.S.). Request Sample Report
5
Europe Office Precision Business Insights, Kemp
House, 152 160 City Road, London EC1V
2NX Asia-Pacific Office Precision Business
Insights, 202, RVS Sree Homes, Opp Bharat
Petroleum Pump,Khanamet Road, Hitech City,
Hyderabad, India 500084 Email sales_at_precisionbu
sinessinsights.com Toll Free 1-866-598-1553